Search

everythinglearnresearchcommunity

for

Search:↓

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

JAK inhibitors may reduce depression in people with alopecia areata.

A Labrador Retriever with pemphigus fully recovered after six weeks of azathioprine treatment.

Higher IL-17A and IL-23 levels are linked to alopecia areata severity and could help in tracking and treating the disease.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Pulsed electric field treatment may help shrink untreated liver tumors.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

ABCD1 gene mutations cause adrenomyeloneuropathy, leading to symptoms like limb weakness and spasticity, with management focusing on rehabilitation and spasticity treatment.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Tofacitinib is effective and safe for treating alopecia areata.

Bortezomib chemotherapy can cause temporary skin rashes.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

New medications could improve treatment for severe alopecia areata in Australia.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

An 81-year-old man's white hair began to regain its original color while he was treated with lenalidomide, suggesting that graying hair might be reversible.

The document did not conclude on apremilast's effectiveness for severe alopecia areata.

Baricitinib helps regrow hair in teens with severe alopecia areata.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.